EVAX - Evaxion Biotech AS - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart

EVAX is currently covered by 2 analysts with an average price target of $12.5. This is a potential upside of $10.25 (455.56%) from yesterday's end of day stock price of $2.25.

Evaxion Biotech AS's activity chart (see below) currently has 9 price targets and 17 ratings on display. The stock rating distribution of EVAX is 100% BUY.

Stock Analyst Price Targets - Review

Highest price target for EVAX is $16, Lowest price target is $9, average price target is $12.5.

Most recent stock forecast was given by SWAYAMPAKULA RAMAKANTH from HC WAINWRIGHT on 24-Apr-2026. First documented stock forecast 30-Jul-2021.

Best performing analysts who are covering EVAX - Evaxion Biotech AS:

Thomas Flaten Swayampakula Ramakanth

Currently out of the existing stock ratings of EVAX, 3 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 01-Aug-2024

$16

$13.75 (611.11%)

6 months 29 days ago
(24-Apr-2026)

0/5 (0%)

$11.97 (297.02%)

Buy Since 30-Jul-2021

$9

$6.75 (300.00%)

$11

8 months 13 days ago
(09-Mar-2026)

0/4 (0%)

$5.92 (192.21%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which analyst most recently updated their price target on EVAX (Evaxion Biotech AS)?

Swayampakula Ramakanth

Which analyst has the lowest performance score on EVAX (Evaxion Biotech AS) with a proven track record?

SWAYAMPAKULA RAMAKANTH

Which analyst has the most public recommendations on EVAX (Evaxion Biotech AS)?

Swayampakula Ramakanth works at HC WAINWRIGHT and has 8 price targets and 14 ratings on EVAX

Which analyst is the currently most bullish on EVAX (Evaxion Biotech AS)?

Swayampakula Ramakanth with the highest potential upside of $13.75

Which analyst is the currently most reserved on EVAX (Evaxion Biotech AS)?

Thomas Flaten with the lowest potential downside of $6.75
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?